PL2718294T3 - Redukcyjne aminowanie 6-keto morfinanów przez katalityczne przeniesienie wodoru - Google Patents

Redukcyjne aminowanie 6-keto morfinanów przez katalityczne przeniesienie wodoru

Info

Publication number
PL2718294T3
PL2718294T3 PL12727996T PL12727996T PL2718294T3 PL 2718294 T3 PL2718294 T3 PL 2718294T3 PL 12727996 T PL12727996 T PL 12727996T PL 12727996 T PL12727996 T PL 12727996T PL 2718294 T3 PL2718294 T3 PL 2718294T3
Authority
PL
Poland
Prior art keywords
reductive amination
hydrogen transfer
catalytic hydrogen
morphinans
keto
Prior art date
Application number
PL12727996T
Other languages
English (en)
Inventor
Christopher W. Grote
Joseph P. Mcclurg
Jr. John E. Johnson
Sarah M. Farris
Original Assignee
SpecGx LLC
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by SpecGx LLC filed Critical SpecGx LLC
Publication of PL2718294T3 publication Critical patent/PL2718294T3/pl

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D489/00Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula:
    • C07D489/02Heterocyclic compounds containing 4aH-8, 9 c- Iminoethano-phenanthro [4, 5-b, c, d] furan ring systems, e.g. derivatives of [4, 5-epoxy]-morphinan of the formula: with oxygen atoms attached in positions 3 and 6, e.g. morphine, morphinone
    • C07D489/04Salts; Organic complexes
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D221/00Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00
    • C07D221/02Heterocyclic compounds containing six-membered rings having one nitrogen atom as the only ring hetero atom, not provided for by groups C07D211/00 - C07D219/00 condensed with carbocyclic rings or ring systems
    • C07D221/22Bridged ring systems
    • C07D221/28Morphinans
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00Medicinal preparations containing organic active ingredients
    • A61K31/33Heterocyclic compounds
    • A61K31/395Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/47Quinolines; Isoquinolines
    • A61K31/485Morphinan derivatives, e.g. morphine, codeine
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • A61P25/04Centrally acting analgesics, e.g. opioids
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D471/00Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
    • C07D471/02Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
    • C07D471/08Bridged systems

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurosurgery (AREA)
  • Neurology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Pain & Pain Management (AREA)
  • Emergency Medicine (AREA)
  • Epidemiology (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)
  • Other In-Based Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
PL12727996T 2011-06-09 2012-06-08 Redukcyjne aminowanie 6-keto morfinanów przez katalityczne przeniesienie wodoru PL2718294T3 (pl)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201161494965P 2011-06-09 2011-06-09
PCT/US2012/041458 WO2012170759A1 (en) 2011-06-09 2012-06-08 Reductive amination of 6-keto morphinans by catalytic hydrogen transfer
EP12727996.6A EP2718294B1 (en) 2011-06-09 2012-06-08 Reductive amination of 6-keto morphinans by catalytic hydrogen transfer

Publications (1)

Publication Number Publication Date
PL2718294T3 true PL2718294T3 (pl) 2019-04-30

Family

ID=46317526

Family Applications (1)

Application Number Title Priority Date Filing Date
PL12727996T PL2718294T3 (pl) 2011-06-09 2012-06-08 Redukcyjne aminowanie 6-keto morfinanów przez katalityczne przeniesienie wodoru

Country Status (13)

Country Link
US (1) US9296699B2 (pl)
EP (1) EP2718294B1 (pl)
JP (1) JP2014516085A (pl)
KR (1) KR20140036215A (pl)
CN (1) CN103717601A (pl)
AU (1) AU2012267780B2 (pl)
BR (1) BR112013031420A2 (pl)
ES (1) ES2698408T3 (pl)
MX (1) MX2013013634A (pl)
PL (1) PL2718294T3 (pl)
RU (1) RU2013157298A (pl)
WO (1) WO2012170759A1 (pl)
ZA (1) ZA201308473B (pl)

Family Cites Families (43)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2578787A (en) 1949-04-09 1951-12-18 Rohm & Haas Reduction of enamines
DE922827C (de) 1951-02-08 1955-01-27 Knoll Ag Verfahren zur Herstellung von quartaeren Ammoniumsalzen, die 2 Tetrahydroisochinolinreste enthalten
US2772270A (en) 1954-10-21 1956-11-27 M J Lewenstein 14-hydroxymorphinone and 8, 14-dihydroxydihydromorphinone
US3717643A (en) 1967-05-04 1973-02-20 Sterling Drug Inc N-substituted-norapomorphines
US4089855A (en) 1976-04-23 1978-05-16 Cornell Research Foundation, Inc. Process for the stereoselective reduction of 6- and 8-keto morphine and morphinan derivatives with formamidinesulfinic acid and compounds obtained thereby
EP0034480A3 (en) 1980-02-14 1982-01-13 Grigg, Ronald Ernest Alkylation of amines
US4521601A (en) 1981-05-20 1985-06-04 The United States Of America As Represented By The Department Of Health & Human Services Practical total synthesis unnatural enantiomers of opium-derived morphinans
US4795813A (en) 1981-08-17 1989-01-03 The Florida Board Of Regents On Behalf Of The Florida State University Synthesis of derivatives of codeine and other 3-O-alkylmorphines
US4443605A (en) 1982-07-30 1984-04-17 Miles Laboratories, Inc. 7β-Arylalkyl-6α, 7 α-oxymethylene-3-methoxy or 3-hydroxy-4, 5α-epoxy-17 methyl or 17-cycloalkyl-methyl morphinans
US4775759A (en) 1984-11-27 1988-10-04 The United States Of America As Represented By The Department Of Health And Human Services Synthesis and utilization of 17-methyl and 17-cyclopropylmethyl-3,14-dihydroxy-4,5α-epoxy 6β-fluoromorphinans (foxy and cyclofoxy) as (18F)-labeled opioid ligands for position emission transaxial tomography (PETT)
US4673679A (en) 1986-05-14 1987-06-16 E. I. Du Pont De Nemours And Company Use of prodrugs of 3-hydroxymorphinans to prevent bitter taste upon buccal, nasal or sublingual administration
US5668285A (en) 1986-10-31 1997-09-16 The United States Of America As Represented By The Department Of Health And Human Services Total synthesis of northebaine, normophine, noroxymorphone enantiomers and derivatives via N-Nor intermediates
US4912114A (en) 1988-03-18 1990-03-27 Sandoz Ltd. Morphinan derivatives
US4991391A (en) 1989-01-27 1991-02-12 Westinghouse Electric Corp. System for cooling in a gas turbine
US5208338A (en) 1991-06-14 1993-05-04 The United States Of America As Represented By The Department Of Health & Human Services. Radiolabeled N-substituted-6-iodo-3,14-dihydroxy-4,5α-epoxymorphinans
DE4132159A1 (de) 1991-09-27 1993-04-01 Boehringer Ingelheim Kg 14-hydroxy-n-(2-methoxyethyl)-7,8-dihydromorphin und -norisomorphin, verfahren zu deren herstellung und deren verwendung als arzneimittel
NZ246687A (en) 1992-01-23 1996-12-20 Toray Industries Morphinan derivative and pharmaceutical compositions thereof
ES2146654T3 (es) * 1993-07-23 2000-08-16 Toray Industries Derivado de morfinano y uso medico.
NZ287243A (en) 1994-05-31 1997-12-19 Mallinckrodt Chemical Inc Process for production of nalbuphine form alpha-noroxymorphol
CN1045442C (zh) 1994-07-20 1999-10-06 中国科学院上海药物研究所 左、右旋氯斯库利啉及它的制备方法和用途
WO1997020789A1 (en) 1995-12-06 1997-06-12 Japan Science And Technology Corporation Process for preparating optically active compounds
DE19548399A1 (de) 1995-12-22 1997-06-26 Basf Ag Rutheniumkomplexe mit einem chiralen, zweizähnigen Phosphinoxazolin-Liganden zur enantioselektiven Transferhydrierung von prochiralen Ketonen
GB9616253D0 (en) 1996-08-01 1996-09-11 Johnson Matthey Plc Preparation of narcotic analgesics
PT102006B (pt) 1997-05-19 2000-06-30 Hovione Sociedade Quimica S A Novo processo de preparacao de azitromicina
GB9821067D0 (en) 1998-09-29 1998-11-18 Zeneca Ltd Transfer hydrogenation process
DE10138140A1 (de) 2001-08-09 2003-02-20 Degussa Verfahren zur Herstellung von Aminen durch reduktive Aminierung von Carbonylverbindungen unter Transfer-Hydrierungsbedingungen
DE10161963A1 (de) 2001-12-17 2003-07-03 Johannes Schuetz 6-Aminomorphinanderivate, Herstellungsverfahren dafür und deren Verwendung
CA2520030A1 (en) 2003-03-26 2004-10-07 Pharmacia & Upjohn Company Llc Process to produce enantiomerically enriched alcohols and amines
US20060182692A1 (en) 2003-12-16 2006-08-17 Fishburn C S Chemically modified small molecules
SK286047B6 (sk) 2004-04-13 2008-01-07 Zentiva, A. S. Spôsob prípravy derivátov 4,5alfa-epoxy-6-oxomorfínanu
US6887999B1 (en) 2004-05-21 2005-05-03 Acura Pharmaceuticals, Inc. Preparation of dihydrocodeine from codeine
CA2574362A1 (en) 2004-07-23 2006-01-26 Pliva-Istrazivanje I Razvoj D.O.O. Process
GB0421687D0 (en) 2004-09-30 2004-11-03 Johnson Matthey Plc Preparation of opiate analgesics
CA2587074C (en) 2004-11-05 2012-09-04 Rensselaer Polytechnic Institute 4-hydroxybenzomorphans
EP1762569A1 (en) 2005-09-12 2007-03-14 Alcasynn Pharmaceuticals Gmbh Novel 6-amino-morphinan derivatives, method of manufacturing them and their application as analgesics
US20100022774A1 (en) 2006-05-25 2010-01-28 Ole Heine Kvernenes Process useful in the preparation of morphinan antagonists
WO2008137672A1 (en) 2007-05-04 2008-11-13 Mallinckrodt Inc. Improved process for the preparation of 6-alpha-hydroxy-n-alkylated opiates
WO2009012005A1 (en) 2007-07-17 2009-01-22 Mallinckrodt Inc. Preparation of n-alkylated opiates by reductive amination
CN101265266B (zh) * 2008-04-23 2011-12-14 南京大学 青藤碱衍生物及其制备方法和应用
AU2009300392B2 (en) 2008-09-30 2014-10-23 SpecGx LLC Processes for the selective amination of ketomorphinans
US8563724B2 (en) 2009-02-23 2013-10-22 Mallinckrodt Llc (+)-6-hydroxy-morphinan or (+)-6-amino-morphinan derivatives
US8471023B2 (en) 2009-06-11 2013-06-25 Mallinckrodt Llc Reductive amination of 6-keto normorphinans by catalytic hydrogen transfer
CN102803267A (zh) * 2009-06-11 2012-11-28 马林克罗特有限公司 通过催化氢转移的6-α-氨基N-取代的吗啡喃的制备

Also Published As

Publication number Publication date
RU2013157298A (ru) 2015-07-20
EP2718294B1 (en) 2018-09-05
AU2012267780A1 (en) 2014-01-09
US20120316343A1 (en) 2012-12-13
EP2718294A1 (en) 2014-04-16
JP2014516085A (ja) 2014-07-07
ES2698408T3 (es) 2019-02-04
WO2012170759A1 (en) 2012-12-13
CN103717601A (zh) 2014-04-09
BR112013031420A2 (pt) 2016-08-16
AU2012267780B2 (en) 2016-09-08
ZA201308473B (en) 2014-08-27
KR20140036215A (ko) 2014-03-25
MX2013013634A (es) 2013-12-12
US9296699B2 (en) 2016-03-29

Similar Documents

Publication Publication Date Title
PL2440562T3 (pl) Otrzymywanie 6-alfa-amino-N-podstawionych morfinanów w wyniku katalitycznego przeniesienia wodoru
EP2703709A4 (en) HYDROGEN GAS STATION
SG11201401488RA (en) Nickel hydrogenation catalyst
IL236711A0 (en) A process for improved synthesis of opioids
IL240503A0 (en) The process of n-dealkylation of tertiary amines
ZA201308180B (en) Multifunctional primary amine, process for its preparation, and use thereof
PL2661475T3 (pl) Reaktor termiczny
HUE037511T2 (hu) Eljárás toluol-diamin elõállítására dinitro-toluol hidrogénezésével
AP2014007591A0 (en) Electromagnetic energy-flux reactor
IL236710A0 (en) A process for improved synthesis of opioids
IL213714A0 (en) Process for preparing cinacalcet hydrochloride
ZA201209328B (en) Method of synthesis of ferroquine by convergent reductive amination
ZA201306991B (en) Moving bed reactor
EP2786737A4 (en) REDUCING AGENT CONTAINING SODIUM BOROHYDRIDE
EP2720547A4 (en) PROCESS FOR BENDAMUSTINE HYDROCHLORIDE
GB2488097B (en) Printing process
ZA201404100B (en) Process for recovery of nalmefene hydrochloride
ZA201306114B (en) Direct purification of a nickel laterite leaching effluent
ZA201205924B (en) Reactor
ZA201307569B (en) Method for producing hydrogenation catalyst
ZA201309209B (en) Process for the preparation of morphine analogs via metal catalyzed n-demethylation/functionalization and intramolecular group transfer
EP2660237A4 (en) METHOD OF PREPARING TERTIARY AMINE
PL2601195T3 (pl) Tandemowy sposób wytwarzania n-alkilomorfinanów
ZA201308473B (en) Reductive amination of 6-keto morphinans by catalytic hydrogen transfer
PL2440561T3 (pl) Redukcyjne aminowanie 6-keto-normorfinanow przez katalityczne przeniesienie wodoru